Lingling Xuan

768 total citations
37 papers, 607 citations indexed

About

Lingling Xuan is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Lingling Xuan has authored 37 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Lingling Xuan's work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Asthma and respiratory diseases (4 papers) and Inflammation biomarkers and pathways (3 papers). Lingling Xuan is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Asthma and respiratory diseases (4 papers) and Inflammation biomarkers and pathways (3 papers). Lingling Xuan collaborates with scholars based in China, Australia and United States. Lingling Xuan's co-authors include Lili Gong, Yali Lv, Qi Hou, Song Yang, Zirui Wan, Lulu Ren, Feifei Han, Lihong Liu, He Liu and Chun‐Suo Yao and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and Scientific Reports.

In The Last Decade

Lingling Xuan

32 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingling Xuan China 17 263 117 105 104 97 37 607
Seon‐Young Han South Korea 15 189 0.7× 48 0.4× 71 0.7× 69 0.7× 74 0.8× 22 647
Kavita Bisht Australia 12 224 0.9× 62 0.5× 34 0.3× 73 0.7× 72 0.7× 32 585
Guoyong Zhang China 12 291 1.1× 156 1.3× 77 0.7× 32 0.3× 66 0.7× 29 605
Maria Gabriella Giganti Italy 14 252 1.0× 72 0.6× 49 0.5× 54 0.5× 34 0.4× 21 567
Zepeng Zhang China 18 483 1.8× 94 0.8× 43 0.4× 41 0.4× 199 2.1× 50 789
Jiaxing Zhang China 14 220 0.8× 95 0.8× 46 0.4× 24 0.2× 84 0.9× 29 575
Tian Shen China 12 342 1.3× 79 0.7× 38 0.4× 31 0.3× 114 1.2× 33 610
Hongyan Lu China 15 442 1.7× 41 0.4× 124 1.2× 42 0.4× 115 1.2× 25 724
Bo Kyung Kim South Korea 16 323 1.2× 106 0.9× 44 0.4× 41 0.4× 113 1.2× 51 865
Zi Long China 15 260 1.0× 81 0.7× 67 0.6× 28 0.3× 76 0.8× 22 608

Countries citing papers authored by Lingling Xuan

Since Specialization
Citations

This map shows the geographic impact of Lingling Xuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Xuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Xuan more than expected).

Fields of papers citing papers by Lingling Xuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingling Xuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Xuan. The network helps show where Lingling Xuan may publish in the future.

Co-authorship network of co-authors of Lingling Xuan

This figure shows the co-authorship network connecting the top 25 collaborators of Lingling Xuan. A scholar is included among the top collaborators of Lingling Xuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingling Xuan. Lingling Xuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Ying, Jian Mu, Simin Lin, et al.. (2025). Dual-targeting antioxidant and anti-glycation strategy inhibits melanogenesis through clinical and mechanistic study. Scientific Reports. 15(1). 35226–35226.
2.
Xuan, Lingling, Lulu Ren, Wen Zhang, Zirui Wan, & Yali Lv. (2025). PANoptosis in acute asthma exacerbation: Identification of key genes and immune dysregulation. European Journal of Pharmacology. 1008. 178308–178308. 1 indexed citations
3.
Xuan, Lingling, Lulu Ren, Wen Zhang, & Zhuoling An. (2025). Identification of Novel Biomarkers Associated with Corticosteroid Resistance in Asthma by Bioinformatics Analysis and Experimental Validation. Journal of Inflammation Research. Volume 18. 12379–12400.
4.
5.
Xuan, Lingling, Song Yang, Lulu Ren, et al.. (2024). Akebia saponin D attenuates allergic airway inflammation through AMPK activation. Journal of Natural Medicines. 78(2). 393–402.
6.
Du, Ping, Lingling Xuan, Ting Hu, Zhuoling An, & Lihong Liu. (2022). Serum Eicosanoids Metabolomics Profile in a Mouse Model of Renal Cell Carcinoma: Predicting the Antitumor Efficacy of Anlotinib. Frontiers in Immunology. 13. 824607–824607. 3 indexed citations
7.
8.
Song, Yang, Ting Hu, He Liu, et al.. (2021). Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury. Biomedicine & Pharmacotherapy. 138. 111441–111441. 34 indexed citations
9.
Lv, Yali, Feifei Han, Lingling Xuan, et al.. (2020). Cytomegalovirus Infection Is a Risk Factor in Gastrointestinal Cancer: A Cross-Sectional and Meta-Analysis Study. Intervirology. 63(1-6). 10–16. 16 indexed citations
10.
Xuan, Lingling, Feifei Han, Lili Gong, et al.. (2020). Ceramide induces MMP-9 expression through JAK2/STAT3 pathway in airway epithelium. Lipids in Health and Disease. 19(1). 196–196. 16 indexed citations
11.
Lv, Yali, Zirui Wan, Song Yang, et al.. (2020). Curcumin inhibits the formation of atherosclerosis in ApoE mice by suppressing cytomegalovirus activity in endothelial cells. Life Sciences. 257. 117658–117658. 21 indexed citations
12.
Han, Feifei, Lulu Ren, Lingling Xuan, et al.. (2020). HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer. Cancer Chemotherapy and Pharmacology. 87(1). 103–112. 4 indexed citations
13.
Xuan, Lingling, Lulu Ren, Feifei Han, et al.. (2019). Cytomegalovirus Infection Exacerbates Experimental Colitis by Promoting IL-23 Production. Inflammation. 43(1). 326–335. 6 indexed citations
14.
Yang, Song, Wen Zhang, Lingling Xuan, et al.. (2019). Akebia Saponin D inhibits the formation of atherosclerosis in ApoE mice by attenuating oxidative stress-induced apoptosis in endothelial cells. Atherosclerosis. 285. 23–30. 32 indexed citations
15.
Gong, Lili, Song Yang, Wen Zhang, et al.. (2019). Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC–MS based lipidomics approach. Journal of Pharmaceutical and Biomedical Analysis. 177. 112848–112848. 24 indexed citations
16.
Xuan, Lingling, Feifei Han, Lili Gong, et al.. (2018). Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis. Lipids in Health and Disease. 17(1). 263–263. 51 indexed citations
17.
Gong, Lili, Song Yang, Feifei Han, et al.. (2017). Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy. Journal of Pharmacological Sciences. 136(4). 189–195. 38 indexed citations
18.
Tan, Chunting, et al.. (2016). Decreased Histone Deacetylase 2 (HDAC2) in Peripheral Blood Monocytes (PBMCs) of COPD Patients. PLoS ONE. 11(1). e0147380–e0147380. 31 indexed citations
19.
Xuan, Lingling, et al.. (2016). Vam3, a Compound Derived from Vitis amurensis Rupr., Attenuated Colitis-Related Tumorigenesis by Inhibiting NF-κB Signaling Pathway. Frontiers in Pharmacology. 7. 311–311. 5 indexed citations
20.
Xuan, Lingling, Chun‐Suo Yao, Jinye Bai, et al.. (2014). Vam3, a resveratrol dimer, inhibits cigarette smoke-induced cell apoptosis in lungs by improving mitochondrial function. Acta Pharmacologica Sinica. 35(6). 779–791. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seon‐Young Han Breakdown of academic impact, for papers by Kavita Bisht Breakdown of academic impact, for papers by Guoyong Zhang Breakdown of academic impact, for papers by Maria Gabriella Giganti Breakdown of academic impact, for papers by Zepeng Zhang Breakdown of academic impact, for papers by Jiaxing Zhang Breakdown of academic impact, for papers by Tian Shen Breakdown of academic impact, for papers by Hongyan Lu Breakdown of academic impact, for papers by Bo Kyung Kim Breakdown of academic impact, for papers by Zi Long
Rankless by CCL
2026